MedPath

Guaifenesin Extended-Release

Guaifenesin Extended-Release

Approved
Approval ID

608b00c5-a2c7-4514-9b46-02954d6675d6

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 27, 2025

Manufacturers
FDA

Precision Dose Inc.

DUNS: 035886746

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Guaifenesin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68094-048
Application NumberANDA078912
Product Classification
M
Marketing Category
C73584
G
Generic Name
Guaifenesin
Product Specifications
Route of AdministrationORAL
Effective DateMay 27, 2025
FDA Product Classification

INGREDIENTS (6)

GuaifenesinActive
Quantity: 600 mg in 1 1
Code: 495W7451VQ
Classification: ACTIB
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED)Inactive
Code: K6MOM3T5YL
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 5/27/2025

PRINCIPAL DISPLAY PANEL - 600 mg Tablet Blister Pack Carton

PrecisionDose™

NDC 68094-048-61
Unit Dose

guaiFENesin
Extended-Release
Tablets,

600 mg

100 Tablets
(10 x 10)

(in each extended-release tablet)
Guaifenesin 600 mg....Expectorant.

Directions: do not crush, chew, or
break tablet take with a full glass of water

Unique Bi-Layer Tablet
GLUTEN FREE

USUAL DOSE: See Enclosed Drug Facts
Store at 20-25°C (68-77°F)

Keep out of reach of children.
Hospital Use Only.

LC1384
R0

Packaged by:
Precision Dose, Inc.
South Beloit, IL 61080

PRINCIPAL DISPLAY PANEL - 600 mg Tablet Blister Pack Carton

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 5/27/2025

Uses

  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 5/27/2025

Packaged by:
Precision Dose, Inc.
South Beloit, IL 61080

For inquiries call Precision Dose, Inc. at 1-800-397-9228 or email druginfo@precisiondose.com

LI1730 Rev. 10/24

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 5/27/2025

Active ingredient (in each extended-release tablet)

Guaifenesin 600 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 5/27/2025

Purpose

Expectorant

WARNINGS SECTION

LOINC: 34071-1Updated: 5/27/2025

Warnings

Do not use

  • for children under 12 years of age

Ask a doctor before use if you have

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 5/27/2025

Directions

  • Use as directed per healthcare professional.
  • do not crush, chew, or break tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. Do not exceed 4 tablets in 24 hours.
  • children under 12 years of age: do not use

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 5/27/2025

Other information

  • store at 20-25°C (68-77°F)

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 5/27/2025

Inactive ingredients

Carbomer homopolymer type B, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 5/27/2025

Questions or comments?

1-800-397-9228

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Guaifenesin Extended-Release - FDA Drug Approval Details